abstract |
The present invention relates to the use of LTBP1 for the diagnosis, prognosis prediction or treatment of gastric cancer, pancreatic cancer or brain cancer, when using LTBP1 of the present invention as a marker for diagnosis, prognosis prediction or prognosis prediction of gastric cancer, pancreatic cancer or brain cancer, high diagnosis It has the advantage of being able to diagnose gastric cancer, pancreatic cancer, or brain cancer with sensitivity and specificity, as well as to predict the prognosis, which can greatly contribute to reduction of mortality due to gastric cancer, pancreatic cancer, or brain cancer, and furthermore, to express the expression of LTBP1 of the present invention. It can be applied to the prevention and treatment of gastric cancer by using an inhibitory agent. |